Computer-assisted diagnostics: Application to prostate cancer

Molecular Urology

Volumn 5, Issue 4, 2001, Pages 175-180

  Babaian, Richard J ^a   Zhang, Zhen ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL NEURAL NETWORK; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER STAGING; COMPUTER ASSISTED DIAGNOSIS; DIAGNOSTIC PROCEDURE; HUMAN; INTERMETHOD COMPARISON; MALE; PATTERN RECOGNITION; PREDICTION; PRIORITY JOURNAL; PROBLEM SOLVING; PROSTATE CANCER; REGRESSION ANALYSIS; REVIEW; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

DIAGNOSIS, COMPUTER-ASSISTED; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEURAL NETWORKS (COMPUTER); PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; TREATMENT OUTCOME;

EID: 0035677022     PISSN: 10915362     EISSN: None     Source Type: Journal    
DOI: 10.1089/10915360152745867     Document Type: Review

References (18)

1. How we know universals
2. Understanding artificial neural networks and exploring their potential applications for the practicing urologist
3. Artificial neural networks in the diagnosis and prognosis of prostate cancer: A pilot study
4. Comparative analysis of prostate specific antigen and its indexes in the detection of prostate cancer
5. Estimation of prostate cancer probability by logistic regression: Free and total prostate specific antigen, digital rectal examination, and heredity are significant variables
6. Predicting the outcome of prostate biopsy in screen-positive men by a multilayer perception network
7. Performance of a neural network in detecting prostate cancer in the prostate specific antigen reflex of 2.5 to 4.0 ng/ml
8. A comparative analysis of sextant and an extended 11-core multisite directed biopsy strategy
9. Artificial neural network analysis (ANNA) of prostatic transrectal ultrasound
10. Novel staging tool for localized prostate cancer: A pilot study using genetic adaptive neural networks
11. Evaluation of prostate cancer patients receiving multiple staging tests, including ProstaScint® scintiscans
12. Artificial neural network model for the assessment of lymph node spread in patients with clinically localized prostate cancer
13. Genetically engineered neural networks for predicting prostate cancer progression after radical prostatectomy
14. A neural network progression for men with Gleason score 3 + 4 versus 4 + 3 tumors after radical prostatectomy
15. Improving ultrasonographic diagnosis of prostate cancer with neural networks